# Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects

> **NCT05135871** · PHASE1 · COMPLETED · sponsor: **LianBio LLC** · enrollment: 45 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Mavacamten

## Key facts

- **NCT ID:** NCT05135871
- **Lead sponsor:** LianBio LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-31
- **Primary completion:** 2022-02-05
- **Final completion:** 2022-02-28
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135871, "Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05135871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*